These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23000076)

  • 1. Cannabinoid CB₁ receptor in the modulation of stress coping behavior in mice: the role of serotonin and different forebrain neuronal subpopulations.
    Häring M; Grieb M; Monory K; Lutz B; Moreira FA
    Neuropharmacology; 2013 Feb; 65():83-9. PubMed ID: 23000076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system.
    Egashira N; Matsuda T; Koushi E; Higashihara F; Mishima K; Chidori S; Hasebe N; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
    Eur J Pharmacol; 2008 Jul; 589(1-3):117-21. PubMed ID: 18565508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice.
    Dubreucq S; Matias I; Cardinal P; Häring M; Lutz B; Marsicano G; Chaouloff F
    Neuropsychopharmacology; 2012 Jul; 37(8):1885-900. PubMed ID: 22434220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoids mediate acute fear adaptation via glutamatergic neurons independently of corticotropin-releasing hormone signaling.
    Kamprath K; Plendl W; Marsicano G; Deussing JM; Wurst W; Lutz B; Wotjak CT
    Genes Brain Behav; 2009 Mar; 8(2):203-11. PubMed ID: 19077175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of delta-9-tetrahydrocannabinol on behavioral despair and on pre- and postsynaptic serotonergic transmission.
    Bambico FR; Hattan PR; Garant JP; Gobbi G
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jul; 38(1):88-96. PubMed ID: 22386778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons.
    Sano K; Mishima K; Koushi E; Orito K; Egashira N; Irie K; Takasaki K; Katsurabayashi S; Iwasaki K; Uchida N; Egawa T; Kitamura Y; Nishimura R; Fujiwara M
    Neuroscience; 2008 Jan; 151(2):320-8. PubMed ID: 18083311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bimodal control of fear-coping strategies by CB₁ cannabinoid receptors.
    Metna-Laurent M; Soria-Gómez E; Verrier D; Conforzi M; Jégo P; Lafenêtre P; Marsicano G
    J Neurosci; 2012 May; 32(21):7109-18. PubMed ID: 22623656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses.
    Steiner MA; Marsicano G; Wotjak CT; Lutz B
    Psychoneuroendocrinology; 2008 Sep; 33(8):1165-70. PubMed ID: 18653287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM; Wakley AA; Tsutsui KT; Laggart JD
    J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic versus pharmacological invalidation of the cannabinoid CB(1) receptor results in differential effects on 'non-associative' memory and forebrain monoamine concentrations in mice.
    Thiemann G; Fletcher BC; Ledent C; Molleman A; Hasenöhrl RU
    Neurobiol Learn Mem; 2007 Nov; 88(4):416-23. PubMed ID: 17884611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptors.
    Zádor F; Otvös F; Benyhe S; Zimmer A; Páldy E
    Neurochem Int; 2012 Aug; 61(3):378-88. PubMed ID: 22613132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CB1 cannabinoid receptor-mediated modulation of food intake in mice.
    Wiley JL; Burston JJ; Leggett DC; Alekseeva OO; Razdan RK; Mahadevan A; Martin BR
    Br J Pharmacol; 2005 Jun; 145(3):293-300. PubMed ID: 15778743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Context-specific reversal of cocaine sensitization by the CB1 cannabinoid receptor antagonist rimonabant.
    Gerdeman GL; Schechter JB; French ED
    Neuropsychopharmacology; 2008 Oct; 33(11):2747-59. PubMed ID: 18059436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus.
    Bambico FR; Cassano T; Dominguez-Lopez S; Katz N; Walker CD; Piomelli D; Gobbi G
    Neuropsychopharmacology; 2010 Sep; 35(10):2083-100. PubMed ID: 20571484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats.
    Järbe TU; DiPatrizio NV
    Behav Pharmacol; 2005 Sep; 16(5-6):373-80. PubMed ID: 16148441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of anxiety by acute blockade and genetic deletion of the CB(1) cannabinoid receptor in mice together with biogenic amine changes in the forebrain.
    Thiemann G; Watt CA; Ledent C; Molleman A; Hasenöhrl RU
    Behav Brain Res; 2009 Jun; 200(1):60-7. PubMed ID: 19162082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.
    Järbe TU; LeMay BJ; Vemuri VK; Vadivel SK; Zvonok A; Makriyannis A
    Psychopharmacology (Berl); 2011 Aug; 216(3):355-65. PubMed ID: 21369753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor.
    Cox ML; Haller VL; Welch SP
    Eur J Pharmacol; 2007 Sep; 570(1-3):50-6. PubMed ID: 17588560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action.
    Schlosburg JE; O'Neal ST; Conrad DH; Lichtman AH
    Psychopharmacology (Berl); 2011 Aug; 216(3):323-31. PubMed ID: 21340468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.